Format

Send to

Choose Destination
Neurology. 2018 Jul 24;91(4):e331-e338. doi: 10.1212/WNL.0000000000005860. Epub 2018 Jun 22.

Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance.

Author information

1
From the National TSE Reference Center (P.H., M.L., T.K., S.G., J.T., M.C., M.S., I.Z.), Department of Neurology, Georg-August University Goettingen; Institute of Neuropathology (M.G., J.M.), University Medical Center Hamburg-Eppendorf, Hamburg; and Institute of Neuropathology (W.S.-S.), Saarland University Medical Center, Germany.
2
From the National TSE Reference Center (P.H., M.L., T.K., S.G., J.T., M.C., M.S., I.Z.), Department of Neurology, Georg-August University Goettingen; Institute of Neuropathology (M.G., J.M.), University Medical Center Hamburg-Eppendorf, Hamburg; and Institute of Neuropathology (W.S.-S.), Saarland University Medical Center, Germany. epicjd@med.uni-goettingen.de.

Abstract

OBJECTIVE:

To validate an amended protocol for clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) including real-time quaking-induced conversion (RT-QuIC) and to observe its use in CJD surveillance.

METHODS:

In the framework of a prospective epidemiologic study, all neuropathologically confirmed cases with sCJD who received CSF RT-QuIC analysis during diagnostic workup (n = 65) and a control group of individuals without CJD (n = 118) were selected to investigate the accuracy of an amended diagnostic protocol. The patients had been referred to the German National Reference Center for Transmissible Spongiform Encephalopathies. The influence of the amended protocol on incidence figures was evaluated in the context of 3 years of surveillance activity (screened cases using 14-3-3 test n = 18,789, highly suspicious cases of CJD n = 704). Annual incidences were calculated with current criteria and the amended protocol.

RESULTS:

The amended protocol showed a sensitivity of 97% and a specificity of 99%. When it was applied to all suspected cases who were referred to the reference center, the assessed incidence of CJD increased from 1.7 to 2.2 per million in 2016.

CONCLUSION:

CJD surveillance remains challenging because information from external health care institutions can be limited. RT-QuIC shows excellent diagnostic accuracy when applied in the clinical setting to symptomatic patients. Data for RT-QuIC alone when applied as a general screening test are not available yet. We propose an amended research protocol that improves early and accurate clinical diagnosis of sCJD during surveillance activities. The use of this protocol will probably lead to a significant increase of the incidence rate.

CLASSIFICATION OF EVIDENCE:

This study provides Class III evidence that for patients with suspected sCJD, criteria for clinical diagnosis plus the CSF RT-QuIC accurately identifies patients with sCJD (sensitivity 97%, specificity 99%).

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center